ARCHIVES

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

This article is from The Cancer Letter archive.

Vol. 14 No. 25 | June 17, 1988

Download PDF Visit The Full Archive

Related Articles

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

January 17, 2003

U.S. Patients Use More Chemotherapy, Less Emergency Care than Canadians

May 27, 2011

In Brief: James Wallace Named CALGB Executive Officer; Gritz Receives First Joseph Cullen Award

September 11, 1992

NCI Bypass Budget Seeks $3.64 Billion

January 20, 1995

Urocidin May Provide Alternative To Cystectomy in BCG Cancers

May 27, 2011

ECOG, ACRIN Agree To Join; NCI’s Goal Of Four Adult Groups Is One Merger Away

March 18, 2011